AIM Rule 26

This page enables investors and potential investors to access core management and financial information in compliance with Rule 26 and the AIM Rules for Companies

Description of the business

Venture Life develops, manufactures and distributes regulated products for the consumer self-care market.

Why we do it

A growing global population living longer drives the ever increasing demand for selfcare and preventative wellness. Combined with global healthcare budgets being under pressure and governments encouraging consumers towards both self-diagnosis and self-medication, means the selfcare market is a continually growing market space.

Where we do it

Within the UK and The Netherlands we have direct access to retail markets, including key pharmacy and grocery multiple retailers. This direct route earns us higher revenues per unit, and in return we only invest money in UK consumer marketing to support the products. Our international business currently follows a B2B model. We partner our products around the world, focusing on key markets. Our partners have local market expertise and they cover all in market costs, so we have no exposure to funding sales, marketing and distribution costs in these locations.

To find out more about us click here.

Country of incorporation and main country of operation

Venture Life Group plc is incorporated in England and Wales and its main country of operation is the UK. The Group’s manufacturing facilities are located in Italy and Sweden.

Details of any other exchanges or trading platforms

The Company is not listed on any other exchanges or trading platforms.

Number of AIM securities in issue

Details of restrictions on transfer of securities

There are no restrictions on the transfer of securities.

Financial information

Company announcements

Corporate governance code

Director’s detail

Director’s responsibilities and board committees

UK city code on takeovers and mergers

The Company is subject to the UK City Code on takeovers and mergers.